Endocannabinoid System Saturation and You: A 55plus Guide

Bottles of CBD being studied by doctor for ECS research

Welcome to a captivating exploration of the endocannabinoid system (ECS) and the extraordinary impact of cannabinoids on our well-being. In this journey, we'll unravel the intricate web of the ECS, a remarkable biological network crucial for maintaining balance and harmony within our bodies. As the unsung hero behind various physiological processes, the ECS plays a pivotal role in regulating mood, sleep, appetite, and more.

Before we begin, it is crucial to introduce the key protagonists of our story – cannabinoids such as CBD, CBG and CBN. These powerful compounds, derived from the cannabis plant, hold the key to unlocking the ECS's full potential. Join us as we embark on a quest to understand how these cannabinoids weave a tapestry of health benefits, from alleviating pain and anxiety to enhancing focus and overall vitality. You’ll witness true magic unfold when the ECS and cannabinoids unite, creating a symphony of well-being that resonates throughout our entire being.

Humble Beginnings

Our story of the ECS begins with the origins and discovery of the endocannabinoid system (ECS), an extraordinary marvel nestled within the fabric of our bodies. We are introduced to an unraveling of the historical roots of the ECS, where scientific revelations were the guiding stars that led to its recognition. From its unassuming beginnings to groundbreaking discoveries, let's navigate this narrative, tracing the evolution of our understanding of the ECS and highlighting its profound significance.

The Endocannabinoid System (ECS) is a complex cell-signaling system discovered in the late 20th century. The journey to understanding this crucial physiological system involves multiple scientific breakthroughs and discoveries. Let’s dive in!

Identification of Cannabinoids (Mid 60’s):

In the 1960s, researchers Raphael Mechoulam and Yechiel Gaoni isolated and synthesized delta-9-tetrahydrocannabinol (THC), the psychoactive compound in cannabis. This marked a significant step in understanding the active components of the plant.

Discovery of Cannabinoid Receptors (Late 80’s):

In the late 1980s, researchers Allyn Howlett and William Devane identified the first cannabinoid receptor in the brain. This receptor, known as CB1, was primarily found in the central nervous system.

CB1 Receptors:

CB1 receptors, short for Cannabinoid Receptor 1, are a type of G protein-coupled receptor found primarily in the central nervous system. These receptors play a crucial role in mediating the effects of endocannabinoids, which are naturally occurring cannabinoids produced by the body, as well as exogenous cannabinoids like CBD.


CB1 receptors are primarily activated by endocannabinoids produced within the body, such as anandamide. They can also be activated by external cannabinoids, including CBD (cannabidiol), the non-psychoactive compound in cannabis.


Stimulation of CB1 receptors is associated with various effects, including altered perception, mood elevation, and modulation of pain sensitivity. The non-psychoactive effects of CBD result from its binding to CB1 receptors in the brain.


CB1 receptors play a role in regulating neurotransmitter release, impacting functions such as memory, appetite, and sleep. Activation of CB1 receptors can inhibit the release of certain neurotransmitters, leading to widespread physiological effects.

Isolation of Anandamide (1992):

In 1992, Mechoulam and his team discovered anandamide, an endogenous cannabinoid produced naturally in the body. This led to the hypothesis that there might be an entire system of receptors and endocannabinoids.

Identification of CB2 Receptors (1993):

In 1993, researchers Xia Zhang and Miles Herkenham identified a second cannabinoid receptor, CB2, primarily located in immune cells. This discovery expanded the understanding of the ECS beyond the central nervous system.

CB2 Receptors:

CB2 receptors, or Cannabinoid Receptor 2, are another type of G protein-coupled receptor that is a crucial component of the endocannabinoid system (ECS). CB2 receptors are primarily found in peripheral tissues, immune cells, and structures associated with the immune system.


CB2 receptors are mainly activated by endocannabinoids, such as 2-arachidonoylglycerol (2-AG). They can also be activated by external cannabinoids, and their activation is not typically associated with psychoactive effects.


Stimulation of CB2 receptors is linked to immunomodulatory effects, anti-inflammatory responses, and potential therapeutic benefits in conditions involving immune system dysregulation. CB2 activation does not produce the euphoria associated with CB1 activation.


CB2 receptors play a crucial role in modulating immune responses and inflammation. Activation of CB2 receptors can result in the suppression of immune cell activity, making them a target for research in conditions characterized by inflammation and immune dysfunction.

Elucidation of ECS Functions (Late 90’s to early 00’s):

Throughout the late 20th century and into the 21st century, researchers uncovered the various functions of the ECS. It was found to play a crucial role in regulating a wide range of physiological processes, including mood, appetite, sleep, immune response, and pain perception.

Clinical Implications and Therapeutic Potential:

The discovery of the ECS opened doors to exploring its therapeutic potential. Researchers began investigating cannabinoids and their impact on various health conditions, leading to the development of cannabinoid-based medications.

The discovery of the ECS represents a milestone in the field of neuroscience and has paved the way for new perspectives on health and wellness. As research progresses, the intricate details of this fascinating system are likely to be further uncovered.

Our Cast of Cannabinoid Characters

In the vast landscape of cannabinoids, our story introduces four remarkable characters - CBD, CBG and CBN - each holding a unique role in the intricate symphony of the endocannabinoid system (ECS).

CBD (Cannabidiol)

Picture a serene hemp field bathed in golden sunlight. Here, we encounter Cannabidiol, or CBD, a non-psychoactive compound derived from the cannabis plant. As we delve into CBD's origins, we discover it flourishing in the leaves, flowers, and stems of hemp. From organic farms to state-of-the-art extraction processes, CBD journeys from plant to product, emerging as a therapeutic treasure.

Interaction with Endocannabinoid System (ECS):

CBD interacts with the endocannabinoid system (ECS), a complex cell-signaling system in the body. The ECS plays a crucial role in regulating various physiological processes, including mood, sleep, appetite, and immune response.

Therapeutic Potential:

Research suggests that CBD may have various therapeutic applications. It is being studied for its potential anti-inflammatory, analgesic (pain-relieving), anxiolytic (anxiety-reducing), and neuroprotective properties. However, the fight for access to more research is needed to fully understand its efficacy and optimal uses for a more natural wellness alternative.

CBD is a versatile compound with potential therapeutic benefits, and its non-intoxicating nature has contributed to its popularity as a wellness supplement for many active seniors. However, individuals considering the use of CBD for specific health concerns should seek guidance from healthcare professionals and stay informed on new updates as research continues to come out on this amazing compound.

CBG (Cannabigerol)

A new character has begun to emerge in the tale of cannabinoids—Cannabigerol, or CBG. Picture a hidden garden within the cannabis plant where CBG, the precursor to CBD and THC, stands as a guardian of ECS balance. Delve into CBG's unique role in modulating the ECS, acting as a regulator for other cannabinoids. As we navigate the uncharted waters of CBG, we unveil its potential to support the ECS in maintaining optimal harmony.

Precursor to Other Cannabinoids:

CBG is considered the precursor to other cannabinoids, as enzymes in the cannabis plant convert CBG into THC, CBD, and other cannabinoids during the plant's growth. This makes CBG an essential compound in the biosynthetic pathway of cannabinoids.

Interaction with Endocannabinoid System (ECS):

CBG interacts with the endocannabinoid system (ECS), similar to other cannabinoids. It may influence various physiological processes, including mood, appetite, and immune function, by binding to cannabinoid receptors in the body.

Potential Therapeutic Benefits:

Research on CBG is in its early stages, but studies suggest potential therapeutic effects. CBG is being investigated for its anti-inflammatory, neuroprotective, antimicrobial properties and potential positive effects on focus and drive. It may also have potential applications in conditions such as glaucoma, inflammatory bowel disease, and certain types of cancer. It is a fascinating and helpful compound for active adults throughout any part of their wellness journey.

Synergistic Effects with Other Cannabinoids:

Some researchers suggest that cannabinoids, including CBG, may exhibit synergistic effects when combined with other cannabinoids and terpenes in what is known as the "entourage effect." This concept implies that the combination of various cannabis compounds may enhance therapeutic benefits. 55plus CBD is very proud of the efficacy of its own line of broad-spectrum products that attempt to unlock this potential without the psychoactive effects of Delta 9 THC.

CBG is a fascinating cannabinoid with unique characteristics and potential therapeutic applications. While research is ongoing, CBG's non-psychoactive nature and preliminary findings make it an area of interest for those exploring the diverse compounds present in the cannabis plant.

CBN (Cannabinol)

As the sun sets, our narrative transitions to the tranquil world of sleep, where CBN takes center stage. Visualize a peaceful bedroom infused with the calming effects of Cannabinol, or CBN. Explore how CBN, often considered the sedative of the cannabinoid family, gently lulls the mind and body into a restful slumber. Stories of individuals overcoming insomnia and sleep disorders paint a vivid picture of CBN's sleep-inducing prowess.

Origin and Formation:

CBN is formed through the oxidation and breakdown of THC. Over time, as THC is exposed to air, light, and heat, it converts into CBN. This process is often referred to as the degradation of THC.

Interaction with Endocannabinoid System (ECS):

CBN interacts with the endocannabinoid system (ECS), similarly to other cannabinoids. It may affect the ECS by binding to cannabinoid receptors, particularly CB1 receptors found in the central nervous system.

Potential Therapeutic Benefits:

Research on CBN is limited compared to other cannabinoids, but it is being explored for potential therapeutic benefits. Some studies suggest that CBN may have anti-inflammatory, analgesic, and potentially sleep-inducing properties which is perfect for active adults who may suffer from insomnia or just general issues with sleep. However, as always, more research is needed to be funded in order to fully understand its effects.

As we conclude this chapter in our cannabinoid saga, the characters - CBD, CBG and CBN - remain at the forefront, each contributing a unique melody to the symphony of wellness. The story is still unfolding today, inviting readers to explore the boundless potential of these cannabinoids in unlocking the secrets of the ECS and enhancing the tapestry of their own well-being as active adults.

Saturating the ECS (Where the Research is Headed):

Enhancing ECS Activity:

The idea of saturating the ECS with exogenous cannabinoids (like 55plus CBD) suggests that providing additional cannabinoids from external sources might enhance the overall activity of the system. This concept is based on the assumption that the ECS can benefit from an increased availability of cannabinoids to modulate various physiological functions resulting in homeostasis.

It's important to note that the understanding of the ECS is complex and evolving, and the notion of "saturating" the system is a topic of ongoing research and discussion.

Optimizing Balance:

Proponents of this idea suggest that one could potentially optimize the balance of the system and address conditions where the ECS may be disregulated. This concept is sometimes linked to the idea of achieving an "entourage effect," where the combination of different cannabinoids and terpenes may have synergistic therapeutic effects.

Individual Variation:

It's crucial to recognize that the response to cannabinoids, both endogenous and exogenous, can vary among individuals. Factors such as genetics, overall health, and the specific condition being addressed can influence how the ECS responds to external cannabinoids.

In the captivating journey through the endocannabinoid system (ECS), cannabinoids like CBD, CBG and CBN emerge as key players, influencing the well-being of active adults by interacting with this intricate biological network. The ECS's historical roots unfold, with significant milestones including the identification of cannabinoids and receptors. CBD, a serene protagonist, interacts with the ECS for potential therapeutic benefits. CBG, the "mother cannabinoid," exhibits unique properties, while CBN, associated with sleep, awaits further research for its potential benefits.

Finally, saturating the ECS with exogenous cannabinoids is a concept under exploration, aiming to optimize its balance for overall well-being for not just active seniors but anyone searching for a more natural approach to well-being.

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.